Koning Corporation
Medical Devices, 5555 Oakbrook Pkwy, Norcross, Georgia, 30093, United States, 11-50 Employees
Phone Number: +18*********
Who is KONING CORPORATION
Koning Corporation develops and manufactures advanced medical imaging systems for breast cancer detection using cone-beam computed tomography technology. This revolutionary technology pro...
Read More
- Headquarters: 5555 Oakbrook Pkwy, Norcross, Georgia, 30093, United States
- Employees: 11-50
- Revenue: $25 Million to $50 Million
Industry: Medical Devices
SIC Code: 5047
Does something look wrong? Fix it. | View contact records from KONING CORPORATION
Koning Corporation Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Koning Corporation
Answer: Koning Corporation's headquarters are located at 5555 Oakbrook Pkwy, Norcross, Georgia, 30093, United States
Answer: Koning Corporation's phone number is +18*********
Answer: Koning Corporation's official website is https://koninghealth.com
Answer: Koning Corporation's revenue is $25 Million to $50 Million
Answer: Koning Corporation's SIC: 5047
Answer: Koning Corporation has 11-50 employees
Answer: Koning Corporation is in Medical Devices
Answer: Koning Corporation contact info: Phone number: +18********* Website: https://koninghealth.com
Answer: Koning Corporation develops and manufactures advanced medical imaging systems for breast cancer detection using cone-beam computed tomography technology. This revolutionary technology provides true 3D images for early breast cancer detection, providing a significantly more accurate and effective test than mammography and tomosynthesis. Koning's vision is to fundamentally change breast cancer is detected and diagnosed, with earlier detection, increased patient comfort and lower costs. We believe our Koning Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. We believe that the power, versatility and lower cost of Koning Breast CT will serve as a viable substitute for many traditional imaging applications. Our hope is to be able to improve survival rates and outcomes for millions of patients. Koning Corporation's core technologies are protected by over 80 patents globally, and has received regulatory approval in the US (FDA), Europe (CE-Mark), China (CFDA), Australia (TPG), and Canada (Health Canada). Koning has been the beneficiary of over $17 M in venture funding and over $20 M in government grants to bring this exciting technology to market. Future versions of our technology are expected to optimize early disease detection, diagnosis, intervention and treatment in numerous areas of the body.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month